Levofloxacin Methyl Ester CAS 862690-19-5
| CAS No. | 862690-19-5 |
| Molecular Formula | C19H22FN3O4 |
| Molecular Weight | 375.39 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
CATO supplies Levofloxacin Methyl Ester (CAS 862690-19-5), a certified reference material (molecular formula C19H22FN3O4, MW 375.39 g/mol) for analytical method development and quality control.
Based on its molecular formula C19H22FN3O4, Levofloxacin Methyl Ester contains a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 375.39 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures Levofloxacin Methyl Ester under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C19H22FN3O4 |
| Molecular Weight | 375.39 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1987 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 3 |
Related Levofloxacin Standards
- Levofloxacin Impurity 34 (CAS 108224-82-4)
- Levofloxacin Impurity 40 (CAS 106939-30-4)
- Levofloxacin impurity 78 (CAS 107359-24-0)
- Levofloxacin Impurity 83 (CAS 1268719-66-9)
- Levofloxacin Impurity 52 (CAS 1152314-62-9)
- Levofloxacin Impurity 88 (CAS CATO-C4X-137188)
- Levofloxacin EP Impurity C(Levofloxacin N-Oxide) (CAS 117678-38-3)
- (R)-Levofloxacin N-Oxide (CAS 117678-37-2)
Recommended Standards
- Retigabine impurity 11 (CAS CATO-C4X-13151)
- Retigabine Impurity 3 (CAS 1263404-73-4)
- Gatifloxacin (CAS 112811-59-3)
- Retigabine Impurity 2 (CAS CATO-C4X-13142)
- 1-phenyl-2-(1H-1,2,4-triazol-1-yl)ethan-1-amine (CAS 953906-04-2)
- 4-(2,5-Dichlorophenyl)azetidin-2-one (CAS 1516742-80-5)
- 2-(4,5-Dichloro-1H-imidazol-1-yl)-N-[2-(1H-indol-3-yl)ethyl]acetamide (CAS 946387-16-2)
- (3R,5R)-5-fluoro-1-(4-methoxybenzyl)piperidin-3-amine (CAS 1415825-12-5)
- 3-Amino-4-(1H-imidazol-1-yl)benzoic acid hydrochloride (CAS 1185293-32-6)
- Chroman-8-carboxylic Acid (CAS 31457-16-6)
- 3-(Aminomethyl)-5-methylpyridin-2-ol (CAS 1250194-21-8)
- 1-(4-Nitrophenyl)piperidin-4-yl 4-methoxybenzoate (CAS 339010-15-0)
- (2R,6S)-2-Methyl-6-undecylpiperidine (CAS 137038-58-5)
- Galanin (1-13)-Neuropeptide Y (25-36) amide (CAS 147138-51-0)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com